Inflammation Moderates Antidepressant Response to Ketamine in a Rodent Model of Treatment-Resistant Depression: Bioenergetic and Inflammatory Markers of Response

被引：0
|
作者：
Tye, Susannah [1 ]
Price, J. Blair [1 ]
Walker, Adam [1 ]
Kruse, Jennifer [1 ]
Cullen, Kathryn [1 ]
Frye, Mark [1 ]
Schwieler, Lilly [1 ]
Erhardt, Sophie [1 ]
机构：
[1] Univ Queensland, St Lucia, Qld, Australia
来源：
NEUROPSYCHOPHARMACOLOGY | 2022年 / 47卷 / SUPPL 1期
关键词：
Treatment Resistant Depression; Ketamine; Insulin; mTOR; Immune System;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P372
引用
收藏
页码：277 / 277
页数：1
相关论文
共 50 条
  • [1] Inflammation Moderates Antidepressant Response to Ketamine in a Rodent Model of Treatment-Resistant Depression: Bioenergetic and Inflammatory Markers of Response
    Tye, Susannah
    Price, J. Blair
    Walker, Adam
    Kruse, Jennifer
    Cullen, Kathryn
    Frye, Mark
    Schwieler, Lilly
    Erhardt, Sophie
    [J]. NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 277 - 277
  • [2] Clinical predictors of antidepressant response to ketamine in unipolar treatment-resistant depression
    Del Sant, L. C.
    Magalhaes, E.
    Lucchese, A. C.
    Palhares Alves, H. N.
    Sarin, L. M.
    Del Porto, J. A.
    Tavares de lacerda, A. L.
    [J]. EUROPEAN PSYCHIATRY, 2017, 41 : S525 - S526
  • [3] Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
    James W. Murrough
    Le-Ben Wan
    Brian Iacoviello
    Katherine A. Collins
    Carly Solon
    Benjamin Glicksberg
    Andrew M. Perez
    Sanjay J. Mathew
    Dennis S. Charney
    Dan V. Iosifescu
    Katherine E. Burdick
    [J]. Psychopharmacology, 2014, 231 : 481 - 488
  • [4] Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression
    Niciu, Mark J.
    Shovestul, Bridget J.
    Jaso, Brittany A.
    Farmer, Cristan
    Luckenbaugh, David A.
    Brutsche, Nancy E.
    Park, Lawrence T.
    Ballard, Elizabeth D.
    Zarat, Carlos A., Jr.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2018, 232 : 310 - 315
  • [5] Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
    Murrough, James W.
    Wan, Le-Ben
    Iacoviello, Brian
    Collins, Katherine A.
    Solon, Carly
    Glicksberg, Benjamin
    Perez, Andrew M.
    Mathew, Sanjay J.
    Charney, Dennis S.
    Iosifescu, Dan V.
    Burdick, Katherine E.
    [J]. PSYCHOPHARMACOLOGY, 2014, 231 (03) : 481 - 488
  • [6] Electrophysiological correlates and predictors of the antidepressant response to repeated ketamine infusions in treatment-resistant depression
    de la Salle, Sara
    Phillips, Jennifer L.
    Blier, Pierre
    Knott, Verner
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2022, 115
  • [7] Features of Dissociation Differentially Predict Antidepressant Response to Ketamine in Treatment-Resistant Major Depression
    Niciu, Mark
    Shovestul, Bridget
    Jaso, Brittany
    Farmer, Cristan
    Luckenbaugh, David
    Park, Lawrence
    Ballard, Elizabeth
    Zarate, Carlos
    [J]. NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S564 - S564
  • [8] Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression
    Park, Minkyung
    Newman, Laura E.
    Gold, Philip W.
    Luckenbaugh, David A.
    Yuan, Peixiong
    Machado-Vieira, Rodrigo
    Zarate, Carlos A., Jr.
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 84 : 113 - 118
  • [9] Synaptic Potentiation Is Critical for Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression
    Cornwell, Brian R.
    Salvadore, Giacomo
    Furey, Maura
    Marquardt, Craig A.
    Brutsche, Nancy E.
    Grillon, Christian
    Zarate, Carlos A., Jr.
    [J]. BIOLOGICAL PSYCHIATRY, 2012, 72 (07) : 555 - 561
  • [10] Dissociative symptoms predict antidepressant response after infusion of ketamine in treatment-resistant depression
    Echegaray, M. V. F.
    Mello, R.
    Correia-Melo, F. S.
    Leal, G. C.
    Jesus-Nunes, A. P.
    Vieira, F.
    Fontes, A. T. C.
    Beanes, G.
    Magnavita, G.
    Bandeira, I. D.
    Lacerda, A. L. T.
    Quarantini, L. C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S321 - S322
12345